bipolar I disorder
bipolar I disorder
Explore linked clinical trials. Standard reference: MONDO:000186632 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Socio-cognitive and Biological Responses to Maltreatment | Bipolar and Related Disorders, bipolar I disorder, bipolar disorder, injury, mood disorder, psychiatric disorder | Recruiting | Not stated | 2026-10-07 | NCT07101107 | |
| Evaluating the Therapeutic Potential of Focal Electrically Administered Seizure Therapy (FEAST) in the Treatment of Depression: A Multicenter Randomized Clinical Trial | bipolar I disorder | Not yet recruiting | Not applicable | 2026-10-05 | NCT07857122 | |
| Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophrenia | Recruiting | Phase 4 | 2026-10-01 | NCT05648591 | |
| An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania | Mania, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bipolar I disorder, nervous system disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07288320 | |
| Safety and Feasibility of DBS for Bipolar Depression | Bipolar and Related Disorders, bipolar I disorder, bipolar disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-22 | NCT07745374 | |
| An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Phase 3 | 2026-09-02 | NCT07217860 | |
| A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-09-02 | NCT07172516 | |
| Open Label Extension Study of NCT06221852 | Bipolar and Related Disorders, Insulin Resistance, Nutritional and Metabolic Diseases, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, bipolar disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, mood disorder, psychiatric disorder, schizoaffective disorder | Enrolling by invitation | Not applicable | 2026-08-17 | NCT06558201 | |
| Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder | Bipolar and Related Disorders, Insulin Resistance, Nutritional and Metabolic Diseases, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, bipolar disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, mood disorder, psychiatric disorder, schizoaffective disorder | Recruiting | Not applicable | 2026-08-17 | NCT06221852 | |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-08-14 | NCT06696755 | |
| Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder | Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophrenia | Recruiting | Phase 3 | 2026-08-14 | NCT05303064 | |
| Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects | Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophrenia | Enrolling by invitation | Phase 3 | 2026-08-14 | NCT04987229 | |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder | Mania, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bipolar I disorder, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-10 | NCT07046494 | |
| A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder | bipolar I disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-28 | NCT07540338 | |
| Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. | bipolar I disorder | Recruiting | Phase 2 | 2026-07-27 | NCT07494305 | |
| A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. | bipolar I disorder, depressive disorder | Recruiting | Phase 3 | 2026-07-27 | NCT04777357 | |
| Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder | anxiety disorder, bipolar I disorder, depressive disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-06-25 | NCT05837104 | |
| Risperidone vs Cariprazine in Acute Mania | bipolar I disorder | Not yet recruiting | Phase 4 | 2026-06-24 | NCT07665073 | |
| CLOZAPINE Response in Biotype-1 | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizoaffective disorder, schizophrenia | Recruiting | Phase 4 | 2026-05-11 | NCT04580134 | |
| Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine | Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder, schizophrenia | Recruiting | Phase 1 / Phase 2 | 2026-05-01 | NCT07185815 | |
| SYNCED - SYNChronized Eating in Bipolar Depression Study | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-05-01 | NCT06560957 | |
| Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders | Alzheimer disease, Frontotemporal Lobar Degeneration, Lewy body dementia, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, basal ganglia disorder, bipolar I disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, depressive disorder, frontotemporal dementia, major depressive disorder, metabolic disease, mood disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy | Enrolling by invitation | Not stated | 2026-04-24 | NCT07239843 | |
| Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-03-23 | NCT03484494 | |
| Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder | Bipolar and Related Disorders, Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, Weight Loss, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, nutritional disorder, obesity disorder, overnutrition, psychiatric disorder | Recruiting | Phase 4 | 2026-03-11 | NCT07213466 | |
| LHC-CIDI-5 in Hong Kong | Bipolar and Related Disorders, Chemically-Induced Disorders, Disruptive, Impulse Control, and Conduct Disorders, Mania, Manic Episode, Neurobehavioral Manifestations, Neurologic Manifestations, Panic Attacks, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stress Disorders, Traumatic, acute stress disorder, alcohol-related disorders, anxiety disorder, bipolar I disorder, bipolar II disorder, bipolar disorder, depressive disorder, generalized anxiety disorder, major depressive disorder, mood disorder, nervous system disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-03-10 | NCT06804525 |